Anthony Ford is the founder of CuraSen Therapeutics. CuraSen Therapeutics has raised $60M in total funding. Latest round: Series B.
Anthony Ford, PhD, is a co-founder of CuraSen Therapeutics, a biotechnology company focused on developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. He transitioned to serve as president and chief scientific officer of CuraSen Therapeutics in October 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library